US healthtech firm Omega ##scope is developing implanted lenses that would create a platform for augmented reality inside the human eye . The company , currently awaiting approval from the US Food and Drug Administration as well as European regulators , has successfully carried out a small - scale clinical trial over the past six months with no ill - effects . Co ##scope founder mark Wortz said the device could offer patients the opportunity to add " different interactive sensors , drug delivery devices and the inclusion of augmented and virtual reality integration " .
US healthtech firm Omega Ophthalmics is developing implanted lenses that would create a platform for augmented reality inside the human eye. The company, currently awaiting approval from the US Food and Drug Administration as well as European regulators, has successfully carried out a small-scale clinical trial over the past six months with no ill-effects. Co-founder Gary Wortz said the space could offer manufacturers the opportunity to add "different interactive sensors, drug delivery devices and the inclusion of augmented and virtual reality integration".